Loxo Oncology (LOXO) Tops Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Loxo Oncology (LOXO) Tops Q1 EPS by 10c

Loxo Oncology Announces First Quarter 2016 Financial Results

May 4, 2016 6:45 AM EDT

STAMFORD, Conn., May 04, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today reported financial results for the first quarter ended March 31, 2016. Loxo Oncology will not be conducting a conference call in conjunction with this earnings release.

"With cash runway well into 2018, we are nicely positioned to bring our programs through new and meaningful milestones, said Josh Bilenker, M.D., chief executive officer of Loxo Oncology. In the first half of 2016, we were able... More